Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/154936
Title: Microfluidic size exclusion chromatography (μSEC) for extracellular vesicles and plasma protein separation
Authors: Leong, Sheng Yuan
Ong, Hong Boon
Tay, Hui Min
Kong, Fang
Upadya, Megha
Gong, Lingyan
Dao, Ming
Dalan, Rinkoo
Hou, Han Wei
Keywords: Science::Biological sciences
Science::Medicine
Issue Date: 2022
Source: Leong, S. Y., Ong, H. B., Tay, H. M., Kong, F., Upadya, M., Gong, L., Dao, M., Dalan, R. & Hou, H. W. (2022). Microfluidic size exclusion chromatography (μSEC) for extracellular vesicles and plasma protein separation. Small, 18(6), 2104470-. https://dx.doi.org/10.1002/smll.202104470
Project: ING-000539 BIO IGN 
ING-001058 BIO IGN 
Journal: Small 
Abstract: Extracellular vesicles (EVs) are recognized as next generation diagnostic bio-markers due to their disease-specific biomolecular cargoes and importance in cell–cell communications. A major bottleneck in EV sample preparation is the inefficient and laborious isolation of nanoscale EVs (≈50–200 nm) from endogenous proteins in biological samples. Herein, a unique microfluidic platform is reported for EV-protein fractionation based on the principle of size exclusion chromatography (SEC). Using a novel rapid (≈20 min) replica molding technique, a fritless microfluidic SEC device (μSEC) is fabricated using thiol-ene polymer (UV glue NOA81, Young’s modulus ≈1 GPa) for high pressure (up to 6 bar) sample processing. Controlled on-chip nano-liter sample plug injection (600 nL) using a modified T-junction injector is first demonstrated with rapid flow switching response time (<1.5 s). Device performance is validated using fluorescent nanoparticles (50 nm), albumin, and breast cancer cells (MCF-7)-derived EVs. As a proof-of-concept for clinical applications, EVs are directly isolated from undiluted human platelet-poor plasma using μSEC and show distinct elution profiles between EVs and proteins based on nanoparticle particle analysis (NTA), Western blot and flow cytometry analysis. Overall, the optically transparent μSEC can be readily automated and integrated with EV detection assays for EVs manufacturing and clinical diagnostics.
URI: https://hdl.handle.net/10356/154936
ISSN: 1613-6810
DOI: 10.1002/smll.202104470
Rights: © 2022 Wiley-VCH GmbH. All rights reserved. This is the peer reviewed version of the following article: Leong, S. Y., Ong, H. B., Tay, H. M., Kong, F., Upadya, M., Gong, L., Dao, M., Dalan, R. & Hou, H. W. (2022). Microfluidic size exclusion chromatography (μSEC) for extracellular vesicles and plasma protein separation. Small, 18(6), 2104470-. https://dx.doi.org/10.1002/smll.202104470, which has been published in final form at https://dx.doi.org/10.1002/smll.202104470. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.
Fulltext Permission: embargo_20230112
Fulltext Availability: With Fulltext
Appears in Collections:LKCMedicine Journal Articles
MAE Journal Articles
SBS Journal Articles

Files in This Item:
File Description SizeFormat 
Microfluidic Size Exclusion Chromatography (μSEC) for Extracellular Vesicles and Plasma Protein Separation.pdf
  Until 2023-01-12
1.01 MBAdobe PDFUnder embargo until Jan 12, 2023

SCOPUSTM   
Citations 50

5
Updated on Nov 27, 2022

Web of ScienceTM
Citations 20

6
Updated on Nov 29, 2022

Page view(s)

99
Updated on Dec 5, 2022

Google ScholarTM

Check

Altmetric


Plumx

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.